Bilateral malignant brenner tumour ovary; an extremely rare occurrence
DOI:
https://doi.org/10.18203/2320-6012.ijrms20260268Keywords:
Malignant brenner tumour, Ovarian neoplasm, Transitional cell carcinoma, Benign brenner tumourAbstract
Malignant Brenner tumours (MBTs) are extremely rare ovarian neoplasms, constituting 1–5% of all Brenner tumours. They are typically found in women of the perimenopausal or postmenopausal age group of 50–70 years. MBT often manifest with nonspecific symptoms such as abdominal pain, abnormal uterine bleeding, and weight loss. Definitive diagnosis is possible on histologic examination only, as imaging features and serologic markers are non-specific and give inconsistent results. Being an extremely rare neoplasm, our knowledge about MBT is restricted to case series and case reports. Adding to the rarity, we report a bilateral MBT ovary in a 55-year-old perimenopausal woman presenting with the chief complaint of bilateral lower abdominal pain and discomfort. Ultrasonographic imaging revealed bilateral large adnexal masses of heterogeneous echogenicity, suggesting bilateral malignant ovarian tumour. CA125 was within the reference value. The patient then underwent total abdominal hysterectomy with bilateral salpingo-oophorectomy, and after the histopathologic examination diagnosis of bilateral MBT was made. Patient is on regular follow-up and was disease-free for 4 years until recently, when she developed pleural effusion and is under further investigation.
Metrics
References
Lax SF, Folkins AK, Palacios J, Xue WC. Brenner tumor. In: WHO Classification of Tumours Editorial Board, editor. Female Genital Tumours. International Agency for Research on Cancer. 2020.
Nasioudis D, Sisti G, Holcomb K, Kanninen T, Witkin SS. Malignant Brenner tumors of the ovary; a population-based analysis. Gynecol Oncol. 2016;142(1):44-9. DOI: https://doi.org/10.1016/j.ygyno.2016.04.538
Wang T, Huang W, Finkelman BS, Zhang H. Malignant Brenner tumor of the ovary: Pathologic evaluation, molecular insights and clinical management. Human Pathology Reports. 2024;36(2):300739. DOI: https://doi.org/10.1016/j.hpr.2024.300739
Gezginç K, Karatayli R, Yazici F, Acar A, Çelik Ç, Çapar M, et al. Malignant Brenner tumor of the ovary: analysis of 13 cases. Int J Clin Oncol. 2012;17(4):324-9. DOI: https://doi.org/10.1007/s10147-011-0290-7
Bouhani M, Slimane M, Sghaier S, Bouida A, Chargui R, Rahal K. Malignant brenner tumor of the ovary: one single institute experience and a review of the literature. Anatol J Fam Med. 2020;3(1):71-5. DOI: https://doi.org/10.5505/anatoljfm.2019.66375
Seidman JD, Ronnett BM, Shih IM, Cho KR, Kurman RJ. Surface Epithelial Tumours of the Ovary. Blaustein’s Pathology of the Female Genital Tract. Springer Science. 2011:679-784. DOI: https://doi.org/10.1007/978-1-4419-0489-8_14
Austin RM, Norris HJ. Malignant Brenner Tumor and Transitional Cell Carcinoma of the Ovary: A Comparison. Int J Gynecol Pathol. 1987;6(1):29-39. Availaible at: https://journals.lww.com/intjgynpathology/fulltext/1987/03000/malignant_brenner_tumor_and_transitional_cell.4.aspx. Accessed on 11 August 2025. DOI: https://doi.org/10.1097/00004347-198703000-00004
Cuatrecasas M, Catasus L, Palacios J, Prat J. Transitional cell tumors of the ovary: a comparative clinicopathologic, immunohistochemical, and molecular genetic analysis of Brenner Tumors and transitional cell carcinomas. Am J Surg Pathol. 2009;33(4):556–67. DOI: https://doi.org/10.1097/PAS.0b013e318188b84c
Ellaithy A. 64P Malignant Brenner tumor of the ovary: Impact of adjuvant chemotherapy, age, race, laterality and stage on survival outcome. ESMO Open. 2023;8 (1):100844. DOI: https://doi.org/10.1016/j.esmoop.2023.100844
Han JH, Kim D Y, Lee SW, Park JY, Kim JH, Kim YM, et al. Intensive systemic chemotherapy is effective against recurrent malignant Brenner tumor of the ovary: An analysis of 10 cases within a single center. Taiwan J Obstet Gynecol. 2015;54(2):178-82. DOI: https://doi.org/10.1016/j.tjog.2014.03.008
Zhang Y, Staley SA, Tucker K, Clark LH. Malignant Brenner tumor of the ovary: Case series and review of treatment strategies. Gynecol Oncol Rep. 2019;28:29-32. DOI: https://doi.org/10.1016/j.gore.2019.02.003